HNL Lab Medicine Executive and Leadership Team

Martin Till, the President & Chief Executive Officer at HNL Lab Medicine, directs the overarching strategic vision for the organization. Overseeing the expansion of diagnostic capabilities, the President & Chief Executive Officer ensures that laboratory services meet the evolving needs of hospitals and industrial clients throughout the region. This leadership role involves coordinating with the Board to maintain high standards of clinical accuracy and operational efficiency. By fostering partnerships with healthcare providers, Martin Till drives the growth of the laboratory network across Pennsylvania and New Jersey. The President & Chief Executive Officer prioritizes the integration of advanced testing technologies to support better patient outcomes. Through consistent focus on market positioning and service quality, the organization maintains a competitive edge in the diagnostic sector. Ultimately, Till secures the long-term sustainability of the laboratory infrastructure while upholding the mission of providing reliable medical data to the broader healthcare community.

David Beckwith, the President & Chief Executive Officer at HNL Lab Medicine, manages the organizational culture and internal governance frameworks. Focusing on the administrative health of the company, the President & Chief Executive Officer optimizes workflows to support the high-volume testing requirements of long-term care facilities and physician offices. This role involves aligning internal resources with the broader mission of delivering timely diagnostic results to diverse healthcare stakeholders. By streamlining communication channels between departments, David Beckwith enhances the operational agility of the laboratory network. The President & Chief Executive Officer monitors performance metrics to ensure that service delivery remains consistent across all regional locations. Through rigorous oversight of administrative processes, the organization achieves greater efficiency in handling complex pathology requests. Ultimately, Beckwith strengthens the foundational systems that allow the laboratory to provide essential diagnostic support to patients and providers throughout the service area.

David Confalone, the Chief Financial Officer at HNL Lab Medicine, manages the fiscal health and capital allocation strategies of the organization. Overseeing financial planning and revenue cycle management, the Chief Financial Officer ensures that the laboratory maintains the resources necessary to invest in advanced diagnostic technology. This leadership role involves monitoring budgetary performance across all regional locations to support sustainable growth. By implementing rigorous financial controls, David Confalone optimizes the cost structure of laboratory operations while maintaining high service standards for hospitals and long-term care facilities. The Chief Financial Officer provides the data-driven insights required for the executive team to make informed decisions regarding market expansion and service diversification. Through careful management of financial risks and opportunities, the organization secures its position as a leader in the health services sector. Ultimately, Confalone supports the long-term financial stability required to deliver essential medical testing to the community.

Warren Erdmann, the Chief Operating Officer at HNL Lab Medicine, oversees the daily execution of laboratory testing and diagnostic workflows. Managing the logistics of specimen collection and processing, the Chief Operating Officer ensures that all facilities maintain strict compliance with clinical standards. This leadership role involves coordinating the deployment of laboratory equipment and personnel across the Pennsylvania and New Jersey footprint. By optimizing supply chain management and laboratory throughput, Warren Erdmann improves the speed and accuracy of diagnostic reporting for hospitals and industrial clients. The Chief Operating Officer works closely with technical teams to implement process improvements that reduce turnaround times for critical pathology results. Through constant monitoring of operational capacity, the organization sustains high-quality service levels for a broad population of patients. Ultimately, Erdmann drives the operational excellence required to support the complex diagnostic needs of the regional healthcare ecosystem.

Jessica Bargilione, the Chief Marketing Officer at HNL Lab Medicine, directs the brand strategy and market outreach initiatives. Overseeing the communication of diagnostic value to physician offices and healthcare systems, the Chief Marketing Officer ensures that the organization remains the preferred partner for laboratory services. This role involves developing targeted campaigns that highlight the breadth of clinical and anatomic pathology results available to regional providers. By analyzing market trends and competitive positioning, Jessica Bargilione expands the reach of the laboratory into new industrial and employer segments. The Chief Marketing Officer collaborates with sales teams to articulate the benefits of the company's comprehensive testing menu. Through strategic engagement with the medical community, the organization builds lasting relationships that support sustained growth. Ultimately, Bargilione strengthens the market presence of the laboratory, ensuring that healthcare providers understand the full scope of diagnostic capabilities offered to patients.

Jordan Olson, the Chief Medical Officer at HNL Lab Medicine, directs the clinical quality and medical standards of the laboratory. Overseeing the pathology teams and diagnostic protocols, the Chief Medical Officer ensures that every test result meets the highest levels of accuracy and scientific integrity. This role involves maintaining compliance with regulatory requirements and advancing the clinical expertise of the staff. By fostering a culture of continuous learning and quality improvement, Jordan Olson supports the delivery of precise diagnostic information to physicians and hospitals. The Chief Medical Officer collaborates with other executives to integrate new testing methodologies that address emerging medical needs within the region. Through rigorous oversight of clinical practices, the organization upholds its reputation for excellence in pathology and diagnostic services. Ultimately, Olson ensures that the laboratory provides the reliable medical data necessary for effective patient care and treatment planning across the entire service network.